Regulated manufacturing, hospital field trials, and regulatory filings now underway with Ebulent Medical in Shenzhen ...
Researchers are developing functional, patient-specific livers using 3D bioprinting and stem cell technology to eliminate the ...
A new white paper from BioDlink, From Complexity to Consistency: How CDMOs Can Unlock One-Step, High-Yield and Homogeneous ...
Swiss medical device manufacturer Ypsomed will invest more than $249 million to build its first U.S. assembly plant here.
New FDA communication introduces a more flexible, risk‑based chemistry, manufacturing, and controls (CMC) framework for cell and gene therapies, including phased data submission to support earlier ...